Medicine composition for treating recurrent abortion due to positive anticardiolipin antibodies
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 徐美英
- Publication Date
- 2016-07-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicine, and relates to a pharmaceutical composition for treating recurrent miscarriage caused by anticardiolipin antibody positive and a preparation method thereof. Background technique
[0002] Recurrent spontaneous abortion (RSA) is a common pregnancy complication, which refers to the spontaneous abortion of two or more fetuses with the same spouse before 28 weeks of pregnancy. The etiology and pathogenesis of this disease are quite complex, and immune factors are also one of the important reasons. Phospholipids are ubiquitous in the human body and are essential components of the placenta and villi. Antiphospholipid antibodies (antiphospholipidantibodies, APA) are antibodies that can react with a variety of antigenic substances containing phospholipid structures, which mainly include anticardiolipin antibodies (anticardiolipinantibody, ACA).
[0003] Anticardiolipin antibodies ar...